Powered by

Clinical Cancer Research Publishes Results Supporting DiviTum as a Technology for Early Evaluation of Metastatic Breast Cancer Treatment

Jan 16, 2020 - PR Newswire

PR Newswire

Biovica, active in cancer diagnostics, today announced that the scientific journal Clinical Cancer Research has published data from the TREnd study, demonstrating the benefits of using DiviTum® when evaluating palbociclib treatment outcome in women with metastatic breast cancer.

"We are very pleased that these results, which were initially presented at the AACR annual meeting 2019, are published in the renowned journal Clinical Cancer Research. The data shows that DiviT...